Financials AusCann Group Holdings Ltd

Equities

AC8

AU000000AC89

Pharmaceuticals

Market Closed - Australian S.E. 02:10:35 2022-08-31 am EDT 5-day change 1st Jan Change
0.04 AUD -4.76% Intraday chart for AusCann Group Holdings Ltd -.--% -.--%

Valuation

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Capitalization 1 348.9 106.2 42.8 43.61 16.3 17.62
Enterprise Value (EV) 1 335.8 70.75 23.73 29.86 10.58 10.32
P/E ratio -44.8 x -13.5 x -6.03 x -4.04 x -0.62 x -1.61 x
Yield - - - - - -
Capitalization / Revenue 6,483 x 158 x 35.4 x 24.2 x 8 x 11.4 x
EV / Revenue 6,241 x 106 x 19.6 x 16.6 x 5.19 x 6.66 x
EV / EBITDA -42.5 x -11 x -3.44 x -3.37 x -3.4 x -8.37 x
EV / FCF -102 x -7.2 x -1.66 x -13.2 x -7.05 x 22.8 x
FCF Yield -0.98% -13.9% -60.1% -7.59% -14.2% 4.38%
Price to Book 24.7 x 2.55 x 1.24 x 0.98 x 0.9 x 2.45 x
Nbr of stocks (in thousands) 276,873 316,997 317,047 440,547 440,547 440,547
Reference price 2 1.260 0.3350 0.1350 0.0990 0.0370 0.0400
Announcement Date 9/23/18 9/25/19 9/29/20 8/29/21 9/30/22 10/26/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Net sales 1 0.0538 0.6706 1.21 1.8 2.038 1.551
EBITDA 1 -7.911 -6.44 -6.896 -8.847 -3.108 -1.234
EBIT 1 -7.942 -6.497 -6.953 -9.506 -4.9 -1.381
Operating Margin -14,758.67% -968.77% -574.43% -528.01% -240.44% -89.05%
Earnings before Tax (EBT) 1 -7.668 -7.649 -7.076 -10.58 -24.94 -10.7
Net income 1 -7.668 -7.649 -7.076 -8.641 -26.36 -10.92
Net margin -14,249.65% -1,140.64% -584.63% -479.98% -1,293.45% -703.9%
EPS 2 -0.0281 -0.0248 -0.0224 -0.0245 -0.0598 -0.0248
Free Cash Flow 1 -3.298 -9.825 -14.26 -2.265 -1.501 0.4524
FCF margin -6,127.59% -1,465.12% -1,177.92% -125.81% -73.67% 29.17%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 9/23/18 9/25/19 9/29/20 8/29/21 9/30/22 10/26/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 13 35.4 19.1 13.8 5.72 7.3
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -3.3 -9.83 -14.3 -2.27 -1.5 0.45
ROE (net income / shareholders' equity) -52.7% -27.4% -18.5% -26.8% -79.7% -84.5%
ROA (Net income/ Total Assets) -32.5% -14.1% -11.1% -14.7% -9.63% -6.7%
Assets 1 23.57 54.24 63.78 58.6 273.6 163
Book Value Per Share 2 0.0500 0.1300 0.1100 0.1000 0.0400 0.0200
Cash Flow per Share 2 0.0500 0.1100 0.0600 0.0300 0.0100 0.0200
Capex 1 0.14 7.14 5.34 0.03 0.08 -
Capex / Sales 260.79% 1,064.66% 441.13% 1.8% 4.16% -
Announcement Date 9/23/18 9/25/19 9/29/20 8/29/21 9/30/22 10/26/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. AC8 Stock
  4. Financials AusCann Group Holdings Ltd